Kindred Biosciences
(KIN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 603 | 1,401 | 1,104 | 1,236 | 515 |
| Cost of Goods | 3,577 | 187 | 139 | 169 | 92 |
| Gross Profit | -2,974 | 1,214 | 965 | 1,067 | 423 |
| Operating Expenses | 19,993 | 16,899 | 16,811 | 15,968 | 17,145 |
| Operating Income | -22,390 | -15,498 | -15,707 | -14,732 | -16,630 |
| Other Income | -371 | -236 | 414 | 425 | 575 |
| Pre-tax Income | -22,761 | -15,734 | -15,293 | -14,307 | -16,055 |
| Net Income Continuous | -22,761 | -15,734 | -15,293 | -14,307 | -16,055 |
| Net Income | $-22,761 | $-15,734 | $-15,293 | $-14,307 | $-16,055 |
| EPS Basic Total Ops | -0.58 | -0.41 | -0.39 | -0.37 | -0.42 |
| EPS Basic Continuous Ops | -0.58 | -0.40 | -0.39 | -0.37 | -0.42 |
| EPS Diluted Total Ops | -0.58 | -0.41 | -0.39 | -0.37 | -0.42 |
| EPS Diluted Continuous Ops | -0.58 | -0.40 | -0.39 | -0.37 | -0.42 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.40 | -0.39 | N/A | N/A |
| EBITDA(a) | $-21,361 | $-14,730 | $-15,228 | $-14,288 | $-16,211 |